Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections
Clinical trial NCT03510351 · COMPLETED
Trial details
- NCT number
- NCT03510351
- Sponsor
- Temple University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-02-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.